Free patient guide · 19 pages · PDF
Stem Cell Therapy for Autoimmune Diseases: A Patient's Guide
Resetting the Immune System Through Regenerative Medicine
What is inside this guide
- Understanding Autoimmune Diseases
- How Stem Cell Therapy Helps
- Treatment at StemCell Longevita
- Results & Recovery
- Getting Started
Chapter 1
Understanding Autoimmune Diseases
What Are Autoimmune Diseases?
Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy tissues. There are over 80 recognized autoimmune conditions, affecting approximately 5-8% of the global population. These conditions can target virtually any organ or tissue, leading to chronic inflammation, tissue damage, and progressive disability.
Common Autoimmune Conditions
Autoimmune diseases share a common thread: immune dysregulation. Stem cell therapy offers a unique approach by modulating the immune system at its core, rather than just suppressing symptoms with medications.
- Systemic Lupus Erythematosus (SLE) — Affects multiple organ systems including skin, joints, kidneys, and the nervous system.
- Rheumatoid Arthritis — Chronic joint inflammation leading to cartilage and bone erosion.
- Multiple Sclerosis — Immune attack on the myelin sheath protecting nerve fibers.
- Hashimoto's Thyroiditis — Immune destruction of thyroid tissue causing hypothyroidism.
- Psoriasis and Psoriatic Arthritis — Skin and joint inflammation driven by immune dysregulation.
Chapter 2
How Stem Cell Therapy Helps
Immune Modulation
Mesenchymal stem cells are powerful immunomodulators. They interact with T -cells, B-cells, dendritic cells, and natural killer cells to recalibrate the immune response. MSCs suppress overactive immune pathways while preserving the body's ability to fight infections. This balanced immune modulation is what makes stem cell therapy uniquely suited for autoimmune conditions. Unlike immunosuppressive drugs that broadly suppress the immune system, MSCs selectively modulate pathogens.
- immune function — calming the autoimmune attack while maintaining protective immunity against
Scientific Support
Multiple clinical trials have demonstrated the efficacy of MSC therapy in autoimmune diseases. A systematic review of 26 clinical studies showed significant improvements in disease activity scores, reduced need for immunosuppressive medications, and sustained remission in a substantial proportion of patients.
- 74%
- Disease Activity Improvement
- 62%
- Reduced Medication Needs
- 85%
- Patient Satisfaction
Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.
Chapter 3
Treatment at StemCell Longevita
Our Autoimmune Protocol
We use a multi-session IV infusion protocol with high-dose umbilical cord-derived MSCs. Treatment is customized based on the specific autoimmune condition, disease severity, and current medication regimen. Our protocol includes careful pre-treatment assessment, gradual cell administration, and close monitoring throughout the treatment period.
Treatment Schedule at Liv Hospital Ulus
- Day 1 — Comprehensive evaluation including autoimmune panels, inflammatory markers, organ function tests, and imaging as needed.
- Day 2-3 — Sequential stem cell IV infusions with careful monitoring of vital signs and immune responses.
- Day 4 — Post-treatment assessment, medication adjustment plan, and discharge with a detailed follow-up schedule.
Chapter 4
Results & Recovery
Expected Outcomes
Many patients begin noticing improvements in symptoms within 4 to 8 weeks after treatment. Common early benefits include reduced fatigue, decreased joint pain and swelling, improved energy levels, and better overall well-being. More significant immune modulation effects develop over 3 to 6 months as the stem cells reprogram immune cell behavior.
Recovery and Monitoring
- Weeks 1-4 — Continue current medications as directed. Light activities recommended. Monitor for any symptom changes.
- Months 1-3 — Gradual symptom improvement expected. Your rheumatologist may begin tapering immunosuppressive medications.
- Months 3-6 — Significant improvements in disease markers often observed. Follow-up labs recommended.
- Months 6-12 — Sustained improvement and potential medication reductions. Consider booster treatment.
- 4-8
- Weeks to Initial Benefits
- 71%
- Achieved Remission or Low Disease Activity
- 18+
- Months Average Benefit Duration
Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.
Chapter 5
Getting Started
Candidacy Criteria
Ideal candidates include patients with diagnosed autoimmune conditions who have not achieved adequate disease control with conventional treatments, experience significant side effects from immunosuppressive medications, or desire a more natural approach to immune modulation. Our team evaluates each case carefully to determine suitability.
Next Steps
Share your medical records, recent lab results, and current medication list for initial evaluation. Receive a personalized treatment plan and honest assessment of expected outcomes within 48 hours. Schedule a consultation to discuss your specific autoimmune condition and treatment options. Coordinate with our patient services team to plan your treatment visit to Istanbul.
Frequently asked questions
Next steps
Download the full guide for the complete chapters, clinical detail and the questions to ask any clinic. Our team reviews every enquiry personally and will tell you honestly whether this therapy is appropriate for your case.
Medical disclaimer
This guide is provided for educational purposes only and is not medical advice, diagnosis or treatment. Outcomes vary between individuals and no specific result is guaranteed. Always consult a qualified healthcare professional before making medical decisions.